Yas Holding Collaborates with Alvogen to Commercialize its Generic Portfolio in MENA Region

 Yas Holding Collaborates with Alvogen to Commercialize its Generic Portfolio in MENA Region

Alvogen Collaborates with Yas Holding to Commercialize its Generic Portfolio in MENA Region

Shots:

  • Yas Holding entered into an exclusive license and distribution agreement with Alvogen to commercialize its targeted generic pharmaceuticals portfolio in MENA region
  • The collaboration will expand Alvogen’s presence in the MENA region including Gulf, KSA, Levant, North Africa and Sub-Saharan Africa and will improve clinical outcomes and QoL of patients in the MENA region
  • Alvogen’s generic portfolio comprises of 28 products for oncology, autoimmune, inflammation and blood diseases and will be commercialized from 2020

Click here to­ read full press release/ article | Ref: Alvogen | Image: Alvogen

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post